Literature DB >> 25742912

Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?

Shreya Sengupta1, Kristen Wroblewski2, Andrew Aronsohn3, Nancy Reau4, K Gautham Reddy5, Donald Jensen6, Helen Te7.   

Abstract

BACKGROUND: Zinc deficiency has been observed in cirrhosis, but management guidelines do not address screening for zinc deficiency. We aim to determine the prevalence of zinc deficiency in different stages of cirrhosis and to correlate zinc levels with complications of cirrhosis and clinical outcomes. Patients who had a diagnosis of cirrhosis and had serum zinc levels drawn from 2007 to 2011 were identified. Demographics, laboratory data, presence of ascites, encephalopathy, and infection were obtained; Child-Pugh and MELD scores were calculated. Stata software was used for data analysis. A total of 163 patients were included in the study.
RESULTS: The median serum zinc level was 0.47 mcg/ml (IQR 0.37-0.63); 83 % of patients were zinc deficient. Zinc deficiency was more prevalent in patients with Child-Pugh score B or C, and with MELD scores ≥15. Zinc levels were lower in alcoholic, hepatitis C, and cholestatic diseases than in other etiologies of liver disease. Zinc levels correlated with INR (r = -0.56, p < 0.001), bilirubin (r = -0.51, p < 0.001), and albumin (r = 0.68, p < 0.001), and were lower in patients with ascites (0.40 vs. 0.57 mcg/ml, p < 0.001), encephalopathy (0.40 vs. 0.53 mcg/ml, p < 0.001), diuretic use (0.45 vs. 0.535 mcg/ml, p = 0.005), and infection (0.32 vs. 0.51 mcg/ml, p < 0.001). Ascites (p = 0.044) and infection (p = 0.009) were independently associated with zinc levels. Zinc-deficient patients had lower transplant-free survival rates than non-deficient patients.
CONCLUSION: Zinc deficiency is highly prevalent in cirrhotic patients with Child-Pugh score B or C, and with MELD score ≥15. Zinc deficiency also correlates with disease severity, infection, and a worse transplant-free survival. Screening for zinc deficiency should be considered in this subset of patients.

Entities:  

Keywords:  End-stage liver disease; Hepatic encephalopathy; Infection; Malnutrition; Survival

Mesh:

Substances:

Year:  2015        PMID: 25742912     DOI: 10.1007/s10620-015-3613-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Zinc and liver cirrhosis.

Authors:  B Gil Extremera; A Maldonado Martin; M Ruiz Martinez; J Cantero Hinojosa; A Diez Ruiz; M D Rodrigo Moreno
Journal:  Acta Gastroenterol Belg       Date:  1990 May-Jun       Impact factor: 1.316

2.  Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.

Authors:  G Marchesini; A Fabbri; G Bianchi; M Brizi; M Zoli
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects.

Authors:  P DePasquale-Jardieu; P J Fraker
Journal:  J Nutr       Date:  1984-10       Impact factor: 4.798

4.  Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis.

Authors:  P W Keeling; W Ruse; J Bull; B Hannigan; R P Thompson
Journal:  Clin Sci (Lond)       Date:  1981-10       Impact factor: 6.124

5.  Reduced leucocyte zinc in liver disease.

Authors:  P W Keeling; R B Jones; P J Hilton; R P Thompson
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

6.  Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.

Authors:  L S Valberg; P R Flanagan; C N Ghent; M J Chamberlain
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

Review 7.  Zinc and immune function: the biological basis of altered resistance to infection.

Authors:  A H Shankar; A S Prasad
Journal:  Am J Clin Nutr       Date:  1998-08       Impact factor: 7.045

8.  Serum concentrations and urinary excretions of zinc in cirrhosis, nephrotic syndrome and renal insufficiency.

Authors:  R D Lindeman; D J Baxter; A A Yunice; S Kraikitpanitch
Journal:  Am J Med Sci       Date:  1978 Jan-Feb       Impact factor: 2.378

9.  Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.

Authors:  O Riggio; F Ariosto; M Merli; M Caschera; A Zullo; G Balducci; V Ziparo; G Pedretti; F Fiaccadori; E Bottari
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite.

Authors:  J J Wirth; P J Fraker; F Kierszenbaum
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

View more
  9 in total

Review 1.  The Prognostic Value of Serum Zinc Levels in Acutely Hospitalized Patients: a Systematic Review.

Authors:  Stefan Rodic; Christopher McCudden; Carl van Walraven
Journal:  Biol Trace Elem Res       Date:  2021-01-20       Impact factor: 3.738

2.  Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy.

Authors:  Nishah N Panchani; Tyler Colvin; Mahmoud Aryan; Mohamed G Shoreibah
Journal:  Cureus       Date:  2022-05-26

Review 3.  Upper Gastrointestinal Cancer and Liver Cirrhosis.

Authors:  Kuo-Shyang Jeng; Chiung-Fang Chang; I-Shyan Sheen; Chi-Juei Jeng; Chih-Hsuan Wang
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

4.  Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.

Authors:  Shafinaz Abd Gani; Suleiman Alhaji Muhammad; Aminu Umar Kura; Farahnaz Barahuie; Mohd Zobir Hussein; Sharida Fakurazi
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

5.  Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

6.  Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis.

Authors:  Gemma Llibre-Nieto; Alba Lira; Mercedes Vergara; Cristina Solé; Meritxell Casas; Valentí Puig-Diví; Gemma Solé; Antonia Humanes; Laia Grau; Josep Maria Barradas; Mireia Miquel; Jordi Sánchez-Delgado
Journal:  Nutrients       Date:  2021-04-10       Impact factor: 5.717

Review 7.  Malnutrition and Alcohol-Associated Hepatitis.

Authors:  Craig J McClain; Cristian D Rios; Sally Condon; Luis S Marsano
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.126

8.  Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.

Authors:  Hirofumi Matsuyama; Keita Matsuura; Hidehiro Ishikawa; Yoshinori Hirata; Natsuko Kato; Atsushi Niwa; Yugo Narita; Hidekazu Tomimoto
Journal:  Brain Behav       Date:  2018-10-25       Impact factor: 2.708

Review 9.  Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson Disease.

Authors:  R G Barber; Zoey A Grenier; Jason L Burkhead
Journal:  Biomedicines       Date:  2021-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.